AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
A NOVEL MONOCLONAL-ANTIBODY 107-1A4 WITH HIGH PROSTATE SPECIFICITY - GENERATION, CHARACTERIZATION OF ANTIGEN EXPRESSION, AND TARGETING OF HUMAN PROSTATE-CANCER XENOGRAFTS
Authors: BROWN LG WEGNER SK WANG H BUHLER KR ARFMAN EW LANGE PH VESSELLA RL
Citation: Lg. Brown et al., A NOVEL MONOCLONAL-ANTIBODY 107-1A4 WITH HIGH PROSTATE SPECIFICITY - GENERATION, CHARACTERIZATION OF ANTIGEN EXPRESSION, AND TARGETING OF HUMAN PROSTATE-CANCER XENOGRAFTS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(4), 1998, pp. 208-215
USE OF THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN TO ENHANCE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - A PROSPECTIVE MULTICENTER CLINICAL-TRIAL
Authors: CATALONA WJ PARTIN AW SLAWIN KM BRAWER MK FLANIGAN RC PATEL A RICHIE JP DEKERNION JB WALSH PC SCARDINO PT LANGE PH SUBONG ENP PARSON RE GASIOR GH LOVELAND KG SOUTHWICK PC
Citation: Wj. Catalona et al., USE OF THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN TO ENHANCE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - A PROSPECTIVE MULTICENTER CLINICAL-TRIAL, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1542-1547
SERUM PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN METASTATIC PROSTATE-CANCER
Authors: LIN DW NOTEBOOM JL BLUMENSTEIN BA ELLIS WJ LANGE PH VESSELLA RL
Citation: Dw. Lin et al., SERUM PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN METASTATIC PROSTATE-CANCER, Urology, 52(3), 1998, pp. 366-371
(111)INDIUM-CAPROMAB PENDETIDE IN EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE-CANCER AFTER RADICAL PROSTATECTOMY - COMMENT
Authors: LANGE PH
Citation: Ph. Lange, (111)INDIUM-CAPROMAB PENDETIDE IN EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE-CANCER AFTER RADICAL PROSTATECTOMY - COMMENT, The Journal of urology, 159(6), 1998, pp. 2046-2047
NOVEL APPLICATION OF FLOW-CYTOMETRY TO SORT CD57(-CANCER CELLS() AND CD44(+) PROSTATE)
Authors: LIU AY TRUE LD LATRAY L VESSELLA RL LANGE PH VANDENENGH G
Citation: Ay. Liu et al., NOVEL APPLICATION OF FLOW-CYTOMETRY TO SORT CD57(-CANCER CELLS() AND CD44(+) PROSTATE), The Journal of urology, 159(5), 1998, pp. 8-8
CELL-CELL INTERACTION IN PSA AND PAP EXPRESSION AND ITS LOSS IN CANCER-CELLS
Authors: LIU AY TRUE LD VESSELLA RL LANGE PH VANDENENGH G
Citation: Ay. Liu et al., CELL-CELL INTERACTION IN PSA AND PAP EXPRESSION AND ITS LOSS IN CANCER-CELLS, The Journal of urology, 159(5), 1998, pp. 20-20
URODYNAMIC EVALUATION AND LONG-TERM RESULTS OF THE GASTRIC NEOBLADDERIN ADULT MALE-PATIENTS
Authors: LIN DW SANTUCCI RA MAYO ME LANGE PH MITCHELL ME
Citation: Dw. Lin et al., URODYNAMIC EVALUATION AND LONG-TERM RESULTS OF THE GASTRIC NEOBLADDERIN ADULT MALE-PATIENTS, The Journal of urology, 159(5), 1998, pp. 190-190
ACTIVATION OF PROUROKINASE AND PRO-PSA BY HK2, A POTENTIAL PROSTATE-SPECIFIC MECHANISM IN AGGRESSIVE PROSTATE-CANCER
Authors: TAKAYAMA TK FUJIKAWA K DAVIE EW LANGE PH
Citation: Tk. Takayama et al., ACTIVATION OF PROUROKINASE AND PRO-PSA BY HK2, A POTENTIAL PROSTATE-SPECIFIC MECHANISM IN AGGRESSIVE PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 428-428
PSA RT-PCR IN BONE-MARROW ASPIRATES FOLLOWING RADICAL PROSTATECTOMY
Authors: ELLIS WJ COREY E MELCHIOR SW VESSELLA RL LANGE PH
Citation: Wj. Ellis et al., PSA RT-PCR IN BONE-MARROW ASPIRATES FOLLOWING RADICAL PROSTATECTOMY, The Journal of urology, 159(5), 1998, pp. 1119-1119
MULTICENTER RT-PCR-PSA CLINICAL-TRIAL FOR PREOPERATIVE STAGING OF PROSTATE-CANCER
Authors: VESSELLA RL LANGE PH BLUMENSTEIN BA GOMELLA LG MORENO JG WOOD DP BEAMAN A MOUL JW SRIVASTAVA S SLAWIN KM SCARDINO PT BUTTYAN R KATZ AE OLSSON CA HESTON WDW FAIR WR OHARA SM VELTRI RW
Citation: Rl. Vessella et al., MULTICENTER RT-PCR-PSA CLINICAL-TRIAL FOR PREOPERATIVE STAGING OF PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 1124-1124
CYSTOPROSTATECTOMY (CP) AND CONTINENT URINARY-DIVERSION (CUR) FOR LOCALLY ADVANCED-CARCINOMA OF THE PROSTATE (CAP)
Authors: MELCHIOR SW LIN DW LANGE PH
Citation: Sw. Melchior et al., CYSTOPROSTATECTOMY (CP) AND CONTINENT URINARY-DIVERSION (CUR) FOR LOCALLY ADVANCED-CARCINOMA OF THE PROSTATE (CAP), The Journal of urology, 159(5), 1998, pp. 1294-1294
THE VALUE OF A REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION ASSAY IN PREOPERATIVE STAGING AND FOLLOW-UP OF PATIENTS WITH PROSTATE-CANCER
Authors: ELLIS WJ VESSELLA RL COREY E ARFMAN EW OSWIN MM MELCHIOR S LANGE PH
Citation: Wj. Ellis et al., THE VALUE OF A REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION ASSAY IN PREOPERATIVE STAGING AND FOLLOW-UP OF PATIENTS WITH PROSTATE-CANCER, The Journal of urology, 159(4), 1998, pp. 1134-1138
LONG-TERM RESULTS OF RADIATION-THERAPY FOR PROSTATE-CANCER RECURRENCEFOLLOWING RADICAL PROSTATECTOMY
Authors: LANGE PH
Citation: Ph. Lange, LONG-TERM RESULTS OF RADIATION-THERAPY FOR PROSTATE-CANCER RECURRENCEFOLLOWING RADICAL PROSTATECTOMY, The Journal of urology, 159(1), 1998, pp. 177-178
EARLY TUMOR-CELL DISSEMINATION IN PATIENTS WITH CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE
Authors: MELCHIOR SW COREY E ELLIS WJ ROSS AA LAYTON TJ OSWIN MM LANGE PH VESSELLA RL
Citation: Sw. Melchior et al., EARLY TUMOR-CELL DISSEMINATION IN PATIENTS WITH CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE, Clinical cancer research, 3(2), 1997, pp. 249-256
IS SCREENING FOR PROSTATE-CANCER THE CURRENT GOLD STANDARD - YES
Authors: LANGE PH
Citation: Ph. Lange, IS SCREENING FOR PROSTATE-CANCER THE CURRENT GOLD STANDARD - YES, European journal of cancer, 33(3), 1997, pp. 354-356
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED PROSTATE GENES - INCREASEDEXPRESSION OF TRANSCRIPTION FACTOR ETS-2 IN PROSTATE-CANCER
Authors: LIU AY COREY E VESSELLA RL LANGE PH TRUE LD HUANG GM NELSON PS HOOD L
Citation: Ay. Liu et al., IDENTIFICATION OF DIFFERENTIALLY EXPRESSED PROSTATE GENES - INCREASEDEXPRESSION OF TRANSCRIPTION FACTOR ETS-2 IN PROSTATE-CANCER, The Prostate, 30(3), 1997, pp. 145-153
ISSUES IN THE ASSESSMENT OF PROSTATE-SPECIFIC ANTIGEN IMMUNOASSAYS - AN UPDATE
Authors: VESSELLA RL LANGE PH
Citation: Rl. Vessella et Ph. Lange, ISSUES IN THE ASSESSMENT OF PROSTATE-SPECIFIC ANTIGEN IMMUNOASSAYS - AN UPDATE, Urologic clinics of North America, 24(2), 1997, pp. 261
EARLY DETECTION OF RECURRENT PROSTATE-CANCER WITH AN ULTRASENSITIVE CHEMILUMINESCENT PROSTATE-SPECIFIC ANTIGEN-ASSAY
Authors: ELLIS WJ VESSELLA RL NOTEBOOM JL LANGE PH WOLFERT RL RITTENHOUSE HG
Citation: Wj. Ellis et al., EARLY DETECTION OF RECURRENT PROSTATE-CANCER WITH AN ULTRASENSITIVE CHEMILUMINESCENT PROSTATE-SPECIFIC ANTIGEN-ASSAY, Urology, 50(4), 1997, pp. 573-579
IS PARTIAL CYSTECTOMY THE TREATMENT OF CHOICE FOR MUCINOUS ADENOCARCINOMA OF THE URACHUS
Authors: SANTUCCI RA TRUE LD LANGE PH
Citation: Ra. Santucci et al., IS PARTIAL CYSTECTOMY THE TREATMENT OF CHOICE FOR MUCINOUS ADENOCARCINOMA OF THE URACHUS, Urology, 49(4), 1997, pp. 536-540
DETERMINATION OF THE REFLEX RANGE AND APPROPRIATE CUTPOINTS FOR PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN 413 MEN REFERRED FOR PROSTATIC EVALUATION USING THE AXSYM SYSTEM
Authors: VASHI AR WOJNO KJ HENRICKS W ENGLAND BA VESSELLA RL LANGE PH WRIGHT GL SCHELLHAMMER PF WEIGAND RA OLSON RM DOWELL BL BORDEN KK OESTERLING JE
Citation: Ar. Vashi et al., DETERMINATION OF THE REFLEX RANGE AND APPROPRIATE CUTPOINTS FOR PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN 413 MEN REFERRED FOR PROSTATIC EVALUATION USING THE AXSYM SYSTEM, Urology, 49(1), 1997, pp. 19-27
PROSTATE-CANCER - THE THERAPEUTIC CHALLENGE OF LOCALLY ADVANCED DISEASE
Authors: BLASKO JC LANGE PH
Citation: Jc. Blasko et Ph. Lange, PROSTATE-CANCER - THE THERAPEUTIC CHALLENGE OF LOCALLY ADVANCED DISEASE, The New England journal of medicine, 337(5), 1997, pp. 340-341
CELL-CELL INTERACTION IN PROSTATE GENE-REGULATION AND CYTODIFFERENTIATION
Authors: LIU AY TRUE LD LATRAY L NELSON PS ELLIS WJ VESSELLA RL LANGE PH HOOD L VANDENENGH G
Citation: Ay. Liu et al., CELL-CELL INTERACTION IN PROSTATE GENE-REGULATION AND CYTODIFFERENTIATION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10705-10710
LONG-TERM RESULTS OF RETROPUBIC PERMANENT (125)IODINE IMPLANTATION OFTHE PROSTATE FOR CLINICALLY LOCALIZED PROSTATIC-CANCER - COMMENT
Authors: BLASKO JC LANGE PH
Citation: Jc. Blasko et Ph. Lange, LONG-TERM RESULTS OF RETROPUBIC PERMANENT (125)IODINE IMPLANTATION OFTHE PROSTATE FOR CLINICALLY LOCALIZED PROSTATIC-CANCER - COMMENT, The Journal of urology, 158(1), 1997, pp. 29-30
SERUM MARKERS AS A PREDICTOR OF RESPONSE DURATION AND PATIENT SURVIVAL AFTER HORMONAL-THERAPY FOR METASTATIC CARCINOMA OF THE PROSTATE
Authors: SMITH JA LANGE PH JANKNEGT RA ABBOU CC DEGERY A
Citation: Ja. Smith et al., SERUM MARKERS AS A PREDICTOR OF RESPONSE DURATION AND PATIENT SURVIVAL AFTER HORMONAL-THERAPY FOR METASTATIC CARCINOMA OF THE PROSTATE, The Journal of urology, 157(4), 1997, pp. 1329-1334
ANDROGENIC INDUCTION OF PROSTATE-SPECIFIC ANTIGEN GENE IS REPRESSED BY PROTEIN-PROTEIN INTERACTION BETWEEN THE ANDROGEN RECEPTOR AND AP-1 C-JUN IN THE HUMAN PROSTATE-CANCER CELL-LINE LNCAP/
Authors: SATO N SADAR MD BRUCHOVSKY N SAATCIOGLU F RENNIE PS SATO S LANGE PH GLEAVE ME
Citation: N. Sato et al., ANDROGENIC INDUCTION OF PROSTATE-SPECIFIC ANTIGEN GENE IS REPRESSED BY PROTEIN-PROTEIN INTERACTION BETWEEN THE ANDROGEN RECEPTOR AND AP-1 C-JUN IN THE HUMAN PROSTATE-CANCER CELL-LINE LNCAP/, The Journal of biological chemistry, 272(28), 1997, pp. 17485-17494
Risultati: 1-25 | 26-50 | 51-61